Kala Pharmaceuticals, Inc. (10)

Browse by Contract Category

Contracts

Fifth Amendment to Exclusive License Agreement, date July 6, 2020, by and between the Johns Hopkins University and the Registrant (Filed With SEC on August 6, 2020)
Form of Employee Restricted Stock Unit Award under 2017 Equity Incentive Plan (Filed With SEC on August 6, 2020)
Amendment No. 2 to Commercial Supply Agreement, dated March 27, 2020, by and between the Registrant and Catalent Pharma Solutions, LLC (Filed With SEC on May 7, 2020)
Underwriting Agreement, dated March 10, 2020, by and among Kala Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc. and Jefferies LLC, as representatives of... (Filed With SEC on March 12, 2020)
Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on February 12, 2020)
Form of Non-Employee Director Restricted Stock Unit Award under 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
Form of Non-Employee Director Deferred Restricted Stock Unit Award under 2017 Equity Incentive Plan (Filed With SEC on May 7, 2020)
Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on May 9, 2019)
Amended and Restated 2017 Employee Stock Purchase Plan (Filed With SEC on March 12, 2019)
Form of Amendment to Offer Letters (Filed With SEC on March 12, 2019)